The biotech sector is vital for our health security and economic growth. The government has leaned heavily on the sector through the pandemic and will in all likelihood continue to do so going forward. Accordingly, leveraging and investing in the sector’s multiple strengths and components, including early stage companies, universities, research institutes, and large multinational companies, will create an environment conducive to bringing high value, next-generation agricultural, health and industrial products to the world and enable the economy and healthcare system to get an early jump on recovery. Now is exactly the time when we should be focusing on the future.
Read the full paper here